Blake Dixon, MD
Sports Medicine · Dover, ARNPI 1518316702
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Boston Scientific at 53.5% of the total. 2025 is the largest year on record at $752, 2.1 times the $367 reported in 2019. That places this record below the midpoint for sports medicine clinicians in AR, where the typical reported total is $2,790.
Across 79 payments — averaging $26.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- AbbVie$232
- Amgen$140
- AstraZeneca$125
- Axsome Therapeutics, Inc.$120
- Pfizer$120
- plus $253 from 7 others
What the payments were for
- Food & beverage$2,128100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 34 | $1,138 |
| AbbVie | 21 | $232 |
| Amgen | 2 | $140 |
| AstraZeneca | 1 | $125 |
| Axsome Therapeutics, Inc. | 5 | $120 |
| Pfizer | 1 | $120 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $77 |
| Lilly USA, LLC | 3 | $54 |
| Exact Sciences | 3 | $43 |
| Paratek Pharmaceuticals, Inc. | 2 | $27 |
| Novo Nordisk | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,128 in reported general payments places this provider in the 45th percentile of 30 sports medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 162 | $165,532 |
| OzempicSemaglutide | 138 | $157,052 |
| TrulicityDulaglutide | 111 | $125,378 |
| EliquisApixaban | 80 | $76,575 |
| LinzessLinaclotide | 35 | $37,695 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $34,887 |
| FarxigaDapagliflozin Propanediol | 41 | $31,825 |
| JardianceEmpagliflozin | 22 | $24,698 |
| JanuviaSitagliptin Phosphate | 20 | $22,272 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $16,000 |
| XareltoRivaroxaban | 15 | $14,050 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $10,835 |
| Spiriva HandihalerTiotropium Bromide | 18 | $9,691 |
| MultaqDronedarone Hcl | 12 | $8,930 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $8,461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $54 | $290,911273 claims |
| Novo NordiskOzempic | $25 | $157,052138 claims |
| PfizerEliquis, Paxlovid | $120 | $79,433103 claims |
| AstraZenecaFarxiga, Symbicort | $125 | $40,28672 claims |
| AbbVieLinzess | $232 | $37,69535 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 30 sports medicine providers in Arkansas.
Other sports medicine in Dover
- Samuel McClatchyFayetteville$57K
- Austin ColeConway$44K
- Christopher DoughertyBentonville$39K
- Gordon BirkHot Springs$20K
- Michael BogatchLittle Rock$19K
- Kirk ReynoldsLittle Rock$18K
- Eric GordonLittle Rock$13K
- Robert MacleodBentonville$11K
- Lauren PriceBryant$11K
- Andrew HeinzelmannFayetteville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.